angiotensin ii has been researched along with Communicable Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alliegro, PV; Alvarez-Belon, L; Bellomo, R; de Backer, D; Forni, L; Landoni, G; Lumlertgul, N; Ostermann, M; Serpa Neto, A; Trapani, T; Wiedenbeck, C; Zacharowski, K | 1 |
| Vanherweghem, JL | 1 |
1 review(s) available for angiotensin ii and Communicable Diseases
| Article | Year |
|---|---|
[Treatment of terminal uremia by iterative hemodialysis: 25 years of change, the experience at the Free University of Brussels].
Topics: Aluminum; Angiotensin II; Chronic Kidney Disease-Mineral and Bone Disorder; Communicable Diseases; Erythropoietin; History, 20th Century; Humans; Insulin; Kidney Failure, Chronic; Renal Dialysis; Renin; Uremia; Vitamin D | 1988 |
1 other study(ies) available for angiotensin ii and Communicable Diseases
| Article | Year |
|---|---|
Angiotensin II infusion in COVID-19: An international, multicenter, registry-based study.
Topics: Adult; Angiotensin II; Communicable Diseases; COVID-19 Drug Treatment; Humans; Registries; SARS-CoV-2 | 2022 |